Aeterna Zentaris Inc. (TSE:AEZS) has released an update.
Institutional Shareholder Services Inc. (ISS) has endorsed the proposed all-stock merger between biopharmaceutical firms Aeterna Zentaris Inc. and Ceapro Inc., citing strong strategic merit and the inability to find alternative proposals. The recommendation comes after thorough negotiations, suggesting the merger could significantly benefit shareholders of both companies. Aeterna Zentaris’ board has expressed satisfaction with ISS’s support for the deal, which aims to create a diversified biopharmaceutical entity.
For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.
